Kumar R, Klinger H, Mueller T. "一种的合成方法" [P]. US Patent, US 11488179 B2, 2022-11-15.
发明人高志强,黄志刚,徐明华. "Method for the Synthesis of (2R,3S,5R)-5-(2-Amino-4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol" [P]. 中国发明专利, 专利号 CN 111347993 A, 授权公告日 2022-10-01.
发明人陈志强,钱学锋,林芳. "A Process for Preparing High-Purity (2R,3S,5R)-5-(2-Amino-4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol" [P]. 中国发明专利, 专利号 CN 109271798 A, 授权公告日 2019-07-10.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2014, 2254, (11), 8136-8140.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2022, 1006, (12), 4330-4359.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3S,5R)-5-(2-Amino-4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol Using HRMS and NMR". Sci. Total Environ., 2018, 527, 6162-6185.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 1440, 8759-8782.